As we move forward into 2025, the pharmaceutical, biotechnology, and medical device industries continue to witness unparalleled growth, much of which is propelled by the groundbreaking work of Contract Research Organizations (CROs). These entities ar ...
FOMAT Medical Research places a high priority on Community and Patient Advocacy Engagement Initiatives. Here are a few of the initiatives that we ran this year, which is part of our ongoing focus within our community engagement team. We recognize ...
Clinical trials are the backbone of medical research, playing a pivotal role in advancing healthcare and improving patient outcomes. These carefully designed studies aim to evaluate the safety, effectiveness, and side effects of new treatments, inter ...
Oxnard, CA- FOMAT Medical Research announced today the launch of its new Phase I capabilities. The expansion will enhance FOMAT's ability to provide efficient and high-quality services to its clients in the pharmaceutical and biotech industries.The e ...
Simon Corman has over 20 years of experience as a cutting-edge leader in clinical research. His strengths revolve around corporate and business development- with an ability to create strategic partnerships with various CROs and Sponsors and form publ ...
FOMAT is committed to providing high-quality services. We also aim to bring diversity and innovative healthcare to underrepresented populations in our community. That is why we present to you our company’s new ambulance! With our ambulance, we plan o ...
The Oxnard Chamber of Commerce has awarded FOMAT as the Innovative Company of the Year. Oxnard, California, October 5th, 2020FOMAT Medical Research, is a company focused on the pharmaceutical industry, based in Oxnard, California, and has over 10 ye ...
Researchers from the University of Montreal Hospital Research Centre (CRCHUM) have developed a two-step combination therapy to destroy cancer cells. In a study published in the journal Nature Communications, they show the superior therapeut ...
Within the pharmaceutical industry, 45% of clinical trials are completed late, or 70%-80% of studies are delayed or do not meet their timelines. Due to these reasons, one of the main goals for a CRO is to create a mitigating strategy that overcomes t ...
hyperCORE International took first place in the inaugural ACRP All-Star Challenge for Sites during the ACRP 2019 annual conference in Nashville. Vanderbilt University Medical Center took second place, and Sarah Cannon Research Institute placed thi ...